세계의 헬스케어용 대체 불가능 토큰(NFT) 시장 : 사용 블록체인별, 용도 분야별, 최종 용도별, 지역별 업계 동향 및 예측(-2035년)

NON-FUNGIBLE TOKENS (NFT) IN HEALTHCARE MARKET

As per Roots Analysis, the global NFT in healthcare market, valued at USD 154.0 million in 2021, is projected to reach USD 208.1 million in 2025 and USD 1,116.8 billion by 2035, representing a CAGR of 18.3% during the forecast period.

The opportunity for NFT in the healthcare market has been distributed across the following segments:

Blockchain Used

• Ethereum
• HyperLedger
• Polygon
• Other Blockchains

Application Area

• Health Records Management
• Supply Chain Management
• Genomics Research
• Health and Wellness
• Clinical Trial Consent
• Other Application Areas

End-user

• Healthcare Professionals
• Patients
• Pharmaceutical Companies
• Academic Institutions / Government Bodies
• Insurance Companies
• Other End-users

Geographical Regions

• North America (US and Canada)
• Europe (Germany, UK, Spain and Rest of the Europe)
• Asia-Pacific (China, South Korea, India and Rest of the Asia-Pacific)
• Middle East and North Africa (Saudi Arabia, UAE and Rest of the Middle East and North Africa)
• Latin America (Brazil, Argentina and Rest of the Latin America)

NFT IN HEALTHCARE MARKET: GROWTH AND TRENDS

The NFT market is a rapidly evolving sector that is transforming several industries by integrating decentralized blockchain technology. The incorporation of blockchain technology has prompted various industries to shift from centralized systems to decentralized networks, offering several advantages, such as enhanced transaction speeds, reduced costs, and improved data integrity. It is worth highlighting that NFTs are stored and tokenized on blockchain and therefore offer several advantages (mentioned above). These advantages have further contributed to the increased adoption of NFTs in recent years. In fact, in 2021, the NFT market generated more than USD 40 billion in revenues by trading NFTs; primarily attributed to an important event in the artwork industry (wherein Beeple, a digital artist, sold a piece of his artwork worth USD 69 million) that marked a significant breakthrough in the history of NFTs.

NFTs are distinct digital representations of assets, such as artwork, medical data, and video clips that have been tokenized through blockchain technology. It is worth noting that NFTs are non-divisible, immutable, and provide high security and privacy, since third parties cannot access the tokenized information. Owing to the abovementioned features, NFTs are being used across multiple disciplines, such as art, supply chain, fashion, gaming, healthcare, and real estate. Further, NFTs have gained significant interest from investors and stakeholders engaged in the cryptocurrency and blockchain market, contributing to their increased adoption.

In healthcare, NFTs are being used for several applications, including tracking supply chain, managing health records, genomics research, blood donation, clinical trial consent, healthcare and wellness programs. Notably, the NFTs for medical records are most commonly used in the healthcare industry, which allows patients to control their health-related data and trade it with pharmaceutical firms and research institutions. Moreover, to fully realize the potential of NFTs in the healthcare sector, various companies providing NFT solutions are also developing innovative platforms that enable secure and transparent storage and sharing of data.

Given the rising awareness and increased adoption of blockchain and related advanced technologies, the demand for NFT solutions in the healthcare industry is increasing at a steady pace. Moreover, the celebrity endorsements of digital assets and the urgent need to handle healthcare data, the NFT in healthcare market is expected to witness steady growth in the forthcoming years.

NFT IN HEALTHCARE MARKET: KEY INSIGHTS

The report delves into the current state of the NFT in healthcare market and identifies potential growth opportunities within the industry. Some key findings from the report include:

• Driven by the need for security and reliability across various healthcare applications, over 30 NFT solutions have been launched / under development; notably, the market landscape primarily features the presence of new entrants.

• Presently, more than 65% of the NFT platforms are available in the market; of these, 30% of the platforms have all the key features, namely data sharing, smart contracts, decentralization, tokenization, immutability and security.

• Around 45% of the deals inked in this domain were focused on enhancing NFT solutions to improve health data management and accessibility; the majority of the intercontinental deals were signed by players based in North America.
• Over the past few years, more than USD 90 million has been raised across various funding rounds by NFT solution providers in healthcare; of which, 80% of the total amount was raised by players based in Europe.
• The rise in adoption of cryptocurrencies coupled with monetization opportunities for patients drives the non-fungible tokens in healthcare market, positioning it for steady growth in the foreseeable future.

• Given the rising awareness regarding principles such as decentralization coupled with unmatched data security offered by NFTs, the market is anticipated to grow at an annualized rate (CAGR) of 18.3% till 2035.

NFT IN HEALTHCARE MARKET: KEY SEGMENTS

NFT Solutions Utilizing Ethereum Blockchain Network is Likely to Dominate the NFT in Healthcare Market During the Forecast Period

Based on the blockchain used, the global NFT in healthcare market is segmented into Ethereum, HyperLedger, Polygon and other blockchains. Currently, the majority share of the NFT in healthcare market is captured by NFT solutions utilizing Ethereum blockchain network. This can be attributed to the fact that Ethereum blockchain offers enhanced security and privacy (as this was the first blockchain to implement smart contracts) and does not require third-party verification. It is worth mentioning that the NFT solutions utilizing other blockchains are likely to grow at a significant pace in the coming years.

Health Records Management Segment is Likely to Hold the Largest Share of the NFT in Healthcare Market During the Forecast Period

Based on the application area, the global NFT in healthcare market is distributed across health records management, supply chain management, genomics research, health and wellness, clinical trial consent and other application areas. Currently, the health records management segment is likely to dominate the overall market, as NFTs enable the tracking of electronic health records effectively, which supports accurate diagnosis and treatment. Notably, this trend is unlikely to change during the forecast period.

Currently, NFT Solutions Catering to Healthcare Professionals Hold the Largest Share of the NFT in Healthcare Market

Based on the end-user, the global NFT in healthcare market is segmented into healthcare professionals, patients, pharmaceutical companies, academic institutions / government bodies, insurance companies and other end-users. It is worth noting that the current market is likely to be dominated by NFT solutions being utilized by healthcare professionals. However, in the coming years, the NFT solutions catering to patient needs are expected to witness substantial growth.

North America Accounts for the Largest Share of the Market

Based on geographical regions, the market is segmented into North America, Europe, Asia-Pacific, Middle East and North Africa, and Latin America. In the current scenario, North America is likely to dominate the NFT in healthcare market. However, owing to the increasing research and development activity, rising awareness and increased adoption of NFT solutions, the NFT in healthcare market in Asia-Pacific is expected to grow at a higher CAGR during the forecast period.

Example Players in the NFT in Healthcare Market

• Aimedis
• BurstIQ
• ChainCode Consulting
• DeHealth
• Epillo Health
• GenoBank.io
• Genomes.io
• IVIRSE
• Molecule
• Rejuve.AI
• TuumIO
• Universal Health Token

NFT IN HEALTHCARE MARKET: RESEARCH COVERAGE

The report on NFT in healthcare market features insights into various sections, including:

• Market Sizing and Opportunity Analysis: An in-depth analysis of NFT in healthcare market, focusing on key market segments, including [A] blockchain used, [B] application area, [C] end-user, and [D] geographical regions.
• Market Impact Analysis: A thorough analysis of various factors, such as drivers, restraints, opportunities, and existing challenges that are likely to impact market growth.
• NFT Solutions Market Landscape: An insightful analysis of various NFT solutions based on several relevant parameters, such as [A] stage of development, [B] key features, [C] application area, and [D] end-user. Additionally, this section also features analyses of the companies engaged in this domain, based on [A] company size, [B] location of headquarters, and [C] year of establishment.
• Company Competitiveness Analysis: An insightful competitiveness analysis of NFT solution providers based on various relevant parameters, such as [A] supplier strength, [B] portfolio strength, and [C] portfolio diversity.
• Company Profiles: Elaborate profiles of leading players developing NFT solutions across various geographies, including North America, Europe, Asia-Pacific and rest of the world, providing details on [A] company overview, [B] NFT solution overview, [C] recent developments and [D] an informed future outlook.
• Partnerships and Collaborations: An insightful analysis of the deals inked by stakeholders engaged in NFT in healthcare industry, based on several parameters, such as [A] year of partnership, [B] type of partnership, [C] type of partner, [D] application area, [E] most active players and [F] geographical distribution of partnership activity.
• Funding and Investment Analysis: An in-depth analysis of funding and investments made in the NFT in healthcare domain, based on relevant parameters, such as [A] year of funding, [B] type of funding, [C] amount invested (USD million), [D] geography, and [E] most active players.
• Case Study: A detailed assessment of the existing and potential use cases of non-fungible tokens across several healthcare applications, highlighting their capacity to revolutionize health data management and enhancing patient care.
• Porter's Five Forces Analysis: An analysis of five competitive forces prevailing in the NFT in healthcare industry, including threats of new entrants, bargaining power of buyers, bargaining power of NFT in healthcare solution providers, threats of substitute products and rivalry among existing competitors.

KEY QUESTIONS ANSWERED IN THIS REPORT

• How many companies are currently engaged in this market?
• Which are the leading companies in this market?
• What factors are likely to influence the evolution of this market?
• What is the current and future market size?
• What is the CAGR of this market?
• How is the current and future market opportunity likely to be distributed across key market segments?
• What types of partnership models are commonly adopted by industry stakeholders?
• What is the ongoing investment trend in this market?

REASONS TO BUY THIS REPORT

• The report provides a comprehensive market analysis, offering detailed revenue projections of the overall market and its specific sub-segments. This information is valuable to both established market leaders and emerging entrants.
• Stakeholders can leverage the report to gain a deeper understanding of the competitive dynamics within the market. By analyzing the competitive landscape, businesses can make informed decisions to optimize their market positioning and develop effective go-to-market strategies.
• The report offers stakeholders a comprehensive overview of the market, including key drivers, barriers, opportunities, and challenges. This information empowers stakeholders to stay abreast of market trends and make data-driven decisions to capitalize on growth prospects.

ADDITIONAL BENEFITS

• Complimentary PPT Insights Packs
• Complimentary Excel Data Packs for all Analytical Modules in the Report
• 10% Free Content Customization
• Detailed Report Walkthrough Session with Research Team
• Free Updated report if the report is 6-12 months old or older

TABLE OF CONTENTS

SECTION I: REPORT OVERVIEW

1. BACKGROUND

• 1.1. Context
• 1.2. Project Objectives

2. RESEARCH METHODOLOGY

• 2.1. Chapter Overview
• 2.2. Research Assumptions
  • 2.2.1. Market Landscape and Market Trends
  • 2.2.2. Market Forecast and Opportunity Analysis
  • 2.2.3. Comparative Analysis
• 2.3. Database Building
  • 2.3.1. Data Collection
  • 2.3.2. Data Validation
  • 2.3.3. Data Analysis
• 2.4. Project Methodology
  • 2.4.1. Secondary Research
    • 2.4.1.1. Annual Reports
    • 2.4.1.2. Academic Research Papers
    • 2.4.1.3. Company Websites
    • 2.4.1.4. Investor Presentations
    • 2.4.1.5. Regulatory Filings
    • 2.4.1.6. White Papers
    • 2.4.1.7. Industry Publications
    • 2.4.1.8. Conferences and Seminars
    • 2.4.1.9. Government Portals
    • 2.4.1.10. Media and Press Releases
    • 2.4.1.11. Newsletters
    • 2.4.1.12. Industry Databases
    • 2.4.1.13. Roots Proprietary Databases
    • 2.4.1.14. Paid Databases and Sources
    • 2.4.1.15. Social Media Portals
    • 2.4.1.16. Other Secondary Sources
  • 2.4.2. Primary Research
    • 2.4.2.1. Types of Primary Research
      • 2.4.2.1.1. Qualitative Research
      • 2.4.2.1.2. Quantitative Research
      • 2.4.2.1.3. Hybrid Approach
    • 2.4.2.2. Advantages of Primary Research
    • 2.4.2.3. Techniques for Primary Research
      • 2.4.2.3.1. Interviews
      • 2.4.2.3.2. Surveys
      • 2.4.2.3.3. Focus Groups
      • 2.4.2.3.4. Observational Research
      • 2.4.2.3.5. Social Media Interactions
    • 2.4.2.4. Key Opinion Leaders Considered in Primary Research
      • 2.4.2.4.1. Company Executives (CXOs)
      • 2.4.2.4.2. Board of Directors
      • 2.4.2.4.3. Company Presidents and Vice Presidents
      • 2.4.2.4.4. Research and Development Heads
      • 2.4.2.4.5. Technical Experts
      • 2.4.2.4.6. Subject Matter Experts
      • 2.4.2.4.7. Scientists
      • 2.4.2.4.8. Doctors and Other Healthcare Providers
    • 2.4.2.5. Ethics and Integrity
      • 2.4.2.5.1. Research Ethics
      • 2.4.2.5.2. Data Integrity
  • 2.4.3. Analytical Tools and Databases
• 2.5. Robust Quality Control

3. MARKET DYNAMICS

• 3.1. Chapter Overview
• 3.2. Forecast Methodology
  • 3.2.1. Top-down Approach
  • 3.2.2. Bottom-up Approach
  • 3.2.3. Hybrid Approach
• 3.3. Market Assessment Framework
  • 3.3.1. Total Addressable Market (TAM)
  • 3.3.2. Serviceable Addressable Market (SAM)
  • 3.3.3. Serviceable Obtainable Market (SOM)
  • 3.3.4. Currently Acquired Market (CAM)
• 3.4. Forecasting Tools and Techniques
  • 3.4.1. Qualitative Forecasting
  • 3.4.2. Correlation
  • 3.4.3. Regression
  • 3.4.4. Extrapolation
  • 3.4.5. Convergence
  • 3.4.6. Sensitivity Analysis
  • 3.4.7. Scenario Planning
  • 3.4.8. Data Visualization
  • 3.4.9. Time Series Analysis
  • 3.4.10. Forecast Error Analysis
• 3.5. Key Considerations
  • 3.5.1. Demographics
  • 3.5.2. Government Regulations
  • 3.5.3. Reimbursement Scenarios
  • 3.5.4. Market Access
  • 3.5.5. Supply Chain
  • 3.5.6. Industry Consolidation
  • 3.5.7. Pandemic / Unforeseen Disruptions Impact
• 3.6. Limitations

4. MACRO-ECONOMIC INDICATORS

• 4.1. Chapter Overview
• 4.2. Market Dynamics
  • 4.2.1. Time Period
    • 4.2.1.1. Historical Trends
    • 4.2.1.2. Current and Forecasted Estimates
  • 4.2.2. Currency Coverage
    • 4.2.2.1. Major Currencies Affecting the Market
    • 4.2.2.2. Factors Affecting Currency Fluctuations on the Industry
    • 4.2.2.3. Impact of Currency Fluctuations on the Industry
  • 4.2.3. Foreign Currency Exchange Rate
    • 4.2.3.1. Impact of Foreign Exchange Rate Volatility on the Market
    • 4.2.3.2. Strategies for Mitigating Foreign Exchange Risk
  • 4.2.4. Recession
    • 4.2.4.1. Assessment of Current Economic Conditions and Potential Impact on the Market
    • 4.2.4.2. Historical Analysis of Past Recessions and Lessons Learnt
  • 4.2.5. Inflation
    • 4.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
    • 4.2.5.2. Potential Impact of Inflation on the Market Evolution
  • 4.2.6. Interest Rates
    • 4.2.6.1. Interest Rates and Their Impact on the Market
    • 4.2.6.2. Strategies for Managing Interest Rate Risk
  • 4.2.7. Commodity Flow Analysis
    • 4.2.7.1. Type of Commodity
    • 4.2.7.2. Origins and Destinations
    • 4.2.7.3. Values and Weights
    • 4.2.7.4. Modes of Transportation
  • 4.2.8. Global Trade Dynamics
    • 4.2.8.1. Import Scenario
    • 4.2.8.2. Export Scenario
    • 4.2.8.3. Trade Policies
    • 4.2.8.4. Strategies for Mitigating the Risks Associated with Trade Barriers
    • 4.2.8.5. Impact of Trade Barriers on the Market
  • 4.2.9. War Impact Analysis
    • 4.2.9.1. Russian-Ukraine War
    • 4.2.9.2. Israel-Hamas War
  • 4.2.10. COVID Impact / Related Factors
    • 4.2.10.1. Global Economic Impact
    • 4.2.10.2. Industry-specific Impact
    • 4.2.10.3. Government Response and Stimulus Measures
    • 4.2.10.4. Future Outlook and Adaptation Strategies
  • 4.2.11. Other Indicators
    • 4.2.11.1. Fiscal Policy
    • 4.2.11.2. Consumer Spending
    • 4.2.11.3. Gross Domestic Product
    • 4.2.11.4. Employment
    • 4.2.11.5. Taxes
    • 4.2.11.6. Stock Market Performance
    • 4.2.11.7. Cross Border Dynamics
• 4.3. Conclusion

SECTION II: QUALITATIVE INSIGHTS

5. EXECUTIVE SUMMARY

6. INTRODUCTION

• 6.1. Overview of Non-fungible Tokens (NFTs)
• 6.2. Blockchain Process
• 6.3. Key Features of NFTs
• 6.4. NFTs Use Cases
• 6.5. Applications of NFTs in Healthcare
• 6.6. Challenges Associated with NFTs in Healthcare Domain
• 6.7. Future Perspectives

SECTION III: MARKET OVERVIEW

7. COMPETITIVE LANDSCAPE

• 7.1. Methodology and Key Parameters
• 7.2. NFT Solutions in Healthcare: Overall Market Landscape
  • 7.2.1. Analysis by Stage of Development
  • 7.2.2. Analysis by Key Features of NFTs
  • 7.2.3. Analysis by Application Area
  • 7.2.4. Analysis by End-user
• 7.3. NFT Solution Providers in Healthcare: Overall Market Landscape
  • 7.3.1. Analysis by Year of Establishment
  • 7.3.2. Analysis by Company Size
  • 7.3.3. Analysis by Location of Headquarters

8. COMPANY COMPETITIVENESS ANALYSIS

• 8.1. Methodology and Key Parameters
• 8.2. Scoring Criteria
• 8.3. Peer Groups
  • 8.3.1. Overview of Peer Groups
• 8.4. NFT in Healthcare Solution Providers: Company Competitiveness Analysis
  • 8.4.1. NFT Solution Providers in North America: Peer Group I
    • 8.4.1.1. Leading Players in Peer Group I
  • 8.4.2. NFT Solution Providers in Europe: Peer Group II
    • 8.4.2.1. Leading Players in Peer Group II
  • 8.4.3. NFT Solution Providers in Asia-Pacific and Rest of the World: Peer Group III
    • 8.4.3.1. Leading Players in Peer Group III
• 8.5. NFT in Healthcare Solution Providers: Benchmarking Analysis
  • 8.5.1. Benchmarking of Supplier Strength Score
  • 8.5.2. Benchmarking of Portfolio Strength Score
  • 8.5.3. Benchmarking of Portfolio Diversity Score

SECTION IV: COMPANY PROFILES

9. COMPANY PROFILES

• 9.1. Overview
• 9.2. Leading Non-fungible Token Solution Providers in Healthcare
  • 9.2.1. Aimedis
    • 9.2.1.1. Company Overview
    • 9.2.1.2. Company Mission
    • 9.2.1.3. Management Team
    • 9.2.1.4. Contact Details
    • 9.2.1.5. NFT Solution Overview
    • 9.2.1.6. Recent Initiatives
  • 9.2.2. BurstIQ
  • 9.2.3. DeHealth
  • 9.2.4. GenoBank.io
  • 9.2.5. Tuumio
• 9.3. Other Prominent Non-fungible Token Solution Providers in Healthcare
  • 9.3.1. ChainCode Consulting
    • 9.3.1.1. Company Mission
    • 9.3.1.2. Management Team
    • 9.3.1.3. NFT Solution Overview
    • 9.3.1.4. Recent Initiatives
  • 9.3.2. Epillo Health
  • 9.3.3. Genomes.io
  • 9.3.4. IVIRSE
  • 9.3.5. Molecule
  • 9.3.6. Rejuve.AI
  • 9.3.7. Universal Health Token

SECTION V: MARKET TRENDS

10. PARTNERSHIPS AND COLLABORATIONS

• 10.1. Partnership Models
• 10.2. Non-fungible Tokens in Healthcare: Partnerships and Collaborations
  • 10.2.1. Analysis by Year of Partnership
  • 10.2.2. Analysis by Type of Partnership
  • 10.2.3. Analysis by Year and Type of Partnership
  • 10.2.4. Analysis by Type of Partner
  • 10.2.5. Analysis by Application Area
  • 10.2.6. Analysis by Geographical Activity
  • 10.2.7. Most Active Players: Analysis by Number of Partnerships

11. FUNDING AND INVESTMENTS

• 11.1. Funding Models
• 11.2. Non-fungible Tokens in Healthcare: Funding and Investments
  • 11.2.1. Analysis by Year of Funding
  • 11.2.2. Analysis of Funding Instances by Type of Funding
  • 11.2.3. Analysis of Funding Instances by Year and Type of Funding
  • 11.2.4. Analysis of Amount Invested by Type of Funding
  • 11.2.5. Analysis of Funding Instances by Country
  • 11.2.6. Most Active Players: Analysis by Amount Raised
• 11.3. Summary and Key Takeaways

12. NON-FUNGIBLE TOKENS IN HEALTHCARE: USE CASES

• 12.1. Overview of NFT Use Cases
  • 12.1.1. Use Case 1: Auctioning Genomic Data
  • 12.1.2. Use Case 2: DNA Kits
  • 12.1.3. Use Case 3: Blood Donation
  • 12.1.4. Use Case 4: Stem Cell Research
  • 12.1.5. Use Case 5: Digital Health Clinics
  • 12.1.6. Use Case 6: Charitable Health NFTs
  • 12.1.7. Use Case 7: Marketing NFTs
  • 12.1.8. Use Case 8: Supply Chain Traceability
• 12.2. Potential NFT Use Cases

SECTION VI: MARKET FORECAST AND OPPORTUNITY ANALYSIS

13. MARKET IMPACT ANALYSIS: DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES

• 13.1. Chapter Overview
• 13.2. Market Drivers
• 13.3. Market Restraints
• 13.4. Market Opportunities
• 13.5. Market Challenges
• 13.6. Conclusion

14. GLOBAL Non-fungible TOKENS in healthcare MARKET

• 14.1. Key Assumptions and Methodology
• 14.2. Global Non-fungible Tokens in Healthcare Market, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 14.2.1. Multivariate Scenario Analysis
    • 14.2.1.1. Conservative Scenario
    • 14.2.1.2. Optimistic Scenario
• 14.3. Key Market Segmentations

15. Non-fungible TOKENS in healthcare MARKET, BY Blockchain Used

• 15.1. Key Assumptions and Methodology
• 15.2. Non-fungible Tokens in Healthcare Market: Distribution by Blockchain Used
  • 15.2.1. Non-fungible Tokens in Healthcare Market for Ethereum Blockchain, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 15.2.2. Non-fungible Tokens in Healthcare Market for Hyperledger Blockchain, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 15.2.3. Non-fungible Tokens in Healthcare Market for Polygon Blockchain, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 15.2.4. Non-fungible Tokens in Healthcare Market for Other Blockchains, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
• 15.3. Data Triangulation and Validation
  • 15.3.1. Secondary Sources
  • 15.3.2. Primary Sources

16. Non-fungible TOKENS in Healthcare MARKET, BY APPLICATION AREA

• 16.1. Key Assumptions and Methodology
• 16.2. Non-fungible Tokens in Healthcare Market: Distribution by Application Area
  • 16.2.1. Non-fungible Tokens in Healthcare Market for Health Records Management, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 16.2.2. Non-fungible Tokens in Healthcare Market for Supply Chain Management, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 16.2.3. Non-fungible Tokens in Healthcare Market for Genomics Research, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 16.2.4. Non-fungible Tokens in Healthcare Market for Health and Wellness, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 16.2.5. Non-fungible Tokens in Healthcare Market for Clinical Trial Consent, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 16.2.6. Non-fungible Tokens in Healthcare Market for Other Application Areas, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
• 16.3. Data Triangulation and Validation
  • 16.3.1. Secondary Sources
  • 16.3.2. Primary Sources

17. Non-fungible TOKENS in healthcare MARKET, BY End-user

• 17.1. Key Assumptions and Methodology
• 17.2. Non-fungible Tokens in Healthcare Market: Distribution by End-user
  • 17.2.1. Non-fungible Tokens in Healthcare Market for Healthcare Professionals, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 17.2.2. Non-fungible Tokens in Healthcare Market for Patients, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 17.2.3. Non-fungible Tokens in Healthcare Market for Pharmaceutical Companies, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 17.2.4. Non-fungible Tokens in Healthcare Market for Academic Institutions / Government Bodies, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 17.2.5. Non-fungible Tokens in Healthcare Market for Insurance Companies, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 17.2.6. Non-fungible Tokens in Healthcare Market for Other End-users, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
• 17.3. Data Triangulation and Validation
  • 17.3.1. Secondary Sources
  • 17.3.2. Primary Sources

18. Non-fungible TOKENS in healthcare MARKET, BY Geographical Regions

• 18.1. Key Assumptions and Methodology
• 18.2. Non-fungible Tokens in Healthcare Market: Distribution by Geographical Regions
  • 18.2.1. Non-fungible Tokens in Healthcare Market in North America, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 18.2.1.1. Non-fungible Tokens in Healthcare Market in the US, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 18.2.1.2. Non-fungible Tokens in Healthcare Market in Canada, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 18.2.2. Non-fungible Tokens in Healthcare Market in Europe, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 18.2.2.1. Non-fungible Tokens in Healthcare Market in Germany, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 18.2.2.2. Non-fungible Tokens in Healthcare Market in the UK, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 18.2.2.3. Non-fungible Tokens in Healthcare Market in Spain, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 18.2.2.4. Non-fungible Tokens in Healthcare Market in Rest of the Europe, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 18.2.3. Non-fungible Tokens in Healthcare Market in Asia-Pacific, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 18.2.3.1. Non-fungible Tokens in Healthcare Market in China, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 18.2.3.2. Non-fungible Tokens in Healthcare Market in the South Korea, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 18.2.3.3. Non-fungible Tokens in Healthcare Market in India, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 18.2.3.4. Non-fungible Tokens in Healthcare Market in Rest of the Asia-Pacific, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 18.2.4. Non-fungible Tokens in Healthcare Market in Middle East and North Africa, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 18.2.4.1. Non-fungible Tokens in Healthcare Market in Saudi Arabia, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 18.2.4.2. Non-fungible Tokens in Healthcare Market in UAE, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 18.2.4.3. Non-fungible Tokens in Healthcare Market in Rest of the Middle East and North Africa, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 18.2.5. Non-fungible Tokens in Healthcare Market in Latin America, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 18.2.5.1. Non-fungible Tokens in Healthcare Market in Brazil, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 18.2.5.2. Non-fungible Tokens in Healthcare Market in Argentina, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
    • 18.2.5.3. Non-fungible Tokens in Healthcare Market in Rest of the Latin America, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
• 18.3 Non-fungible Tokens in Healthcare Market, By Geographical Regions: Market Dynamics Assessment
  • 18.3.1. Penetration-Growth (P-G) Matrix
  • 18.3.2. Market Movement Analysis
• 18.4. Data Triangulation and Validation
  • 18.4.1. Secondary Sources
  • 18.4.2. Primary Sources

SECTION VII: MARKET OPPORTUNITY ANALYSIS WITHIN GEOGRAPHICAL REGIONS**

19. MARKET OPPORTUNITY ANALYSIS: NORTH AMERICA

• 19.1. Non-fungible Tokens in Healthcare Market in North America: Distribution by Blockchain Used
  • 19.1.1. Non-fungible Tokens in Healthcare Market in North America for Ethereum Blockchain, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 19.1.2. Non-fungible Tokens in Healthcare Market in North America for Hyperledger Blockchain, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 19.1.3. Non-fungible Tokens in Healthcare Market in North America for Polygon Blockchain, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 19.1.4. Non-fungible Tokens in Healthcare Market in North America for Other Blockchains, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
• 19.2. Non-fungible Tokens in Healthcare Market in North America: Distribution by Application Area
  • 19.2.1. Non-fungible Tokens in Healthcare Market in North America for Health Records Management, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 19.2.2. Non-fungible Tokens in Healthcare Market in North America for Supply Chain Management, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 19.2.3. Non-fungible Tokens in Healthcare Market in North America for Genomics Research, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 19.2.4. Non-fungible Tokens in Healthcare Market in North America for Health and Wellness, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 19.2.5. Non-fungible Tokens in Healthcare Market in North America for Clinical Trial Consent, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 19.2.6. Non-fungible Tokens in Healthcare Market in North America for Other Application Areas, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
• 19.3. Non-fungible Tokens in Healthcare Market in North America: Distribution by End-user
  • 19.3.1. Non-fungible Tokens in Healthcare Market in North America for Healthcare Professionals, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 19.3.2. Non-fungible Tokens in Healthcare Market in North America for Patients, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 19.3.3. Non-fungible Tokens in Healthcare Market in North America for Pharmaceutical Companies, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 19.3.4. Non-fungible Tokens in Healthcare Market in North America for Academic Institutions / Government Bodies, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 19.3.5. Non-fungible Tokens in Healthcare Market in North America for Insurance Companies, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 19.3.6. Non-fungible Tokens in Healthcare Market in North America for Other End-users, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)

20. MARKET OPPORTUNITY ANALYSIS: EUROPE

• 20.1. Non-fungible Tokens in Healthcare Market in Europe: Distribution by Blockchain Used
  • 20.1.1. Non-fungible Tokens in Healthcare Market in Europe for Ethereum Blockchain, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 20.1.2. Non-fungible Tokens in Healthcare Market in Europe for Hyperledger Blockchain, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 20.1.3. Non-fungible Tokens in Healthcare Market in Europe for Polygon Blockchain, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 20.1.4. Non-fungible Tokens in Healthcare Market in Europe for Other Blockchains, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
• 20.2. Non-fungible Tokens in Healthcare Market in Europe: Distribution by Application Area
  • 20.2.1. Non-fungible Tokens in Healthcare Market in Europe for Health Records Management, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 20.2.2. Non-fungible Tokens in Healthcare Market in Europe for Supply Chain Management, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 20.2.3. Non-fungible Tokens in Healthcare Market in Europe for Genomics Research, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 20.2.4. Non-fungible Tokens in Healthcare Market in Europe for Health and Wellness, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 20.2.5. Non-fungible Tokens in Healthcare Market in Europe for Clinical Trial Consent, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 20.2.6. Non-fungible Tokens in Healthcare Market in Europe for Other Application Areas, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
• 20.3. Non-fungible Tokens in Healthcare Market in Europe: Distribution by End-user
  • 20.3.1. Non-fungible Tokens in Healthcare Market in Europe for Healthcare Professionals, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 20.3.2. Non-fungible Tokens in Healthcare Market in Europe for Patients, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 20.3.3. Non-fungible Tokens in Healthcare Market in Europe for Pharmaceutical Companies, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 20.3.4. Non-fungible Tokens in Healthcare Market in Europe for Academic Institutions / Government Bodies, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 20.3.5. Non-fungible Tokens in Healthcare Market in Europe for Insurance Companies, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 20.3.6. Non-fungible Tokens in Healthcare Market in Europe for Other End-users, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)

21. MARKET OPPORTUNITY ANALYSIS: ASIA-PACIFIC

• 21.1. Non-fungible Tokens in Healthcare Market in Asia-Pacific: Distribution by Blockchain Used
  • 21.1.1. Non-fungible Tokens in Healthcare Market in Asia-Pacific for Ethereum Blockchain, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 21.1.2. Non-fungible Tokens in Healthcare Market in Asia-Pacific for Hyperledger Blockchain, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 21.1.3. Non-fungible Tokens in Healthcare Market in Asia-Pacific for Polygon Blockchain, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 21.1.4. Non-fungible Tokens in Healthcare Market in Asia-Pacific for Other Blockchains, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
• 21.2. Non-fungible Tokens in Healthcare Market in Asia-Pacific: Distribution by Application Area
  • 21.2.1. Non-fungible Tokens in Healthcare Market in Asia-Pacific for Health Records Management, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 21.2.2. Non-fungible Tokens in Healthcare Market in Asia-Pacific for Supply Chain Management, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 21.2.3. Non-fungible Tokens in Healthcare Market in Asia-Pacific for Genomics Research, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 21.2.4. Non-fungible Tokens in Healthcare Market in Asia-Pacific for Health and Wellness, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 21.2.5. Non-fungible Tokens in Healthcare Market in Asia-Pacific for Clinical Trial Consent, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 21.2.6. Non-fungible Tokens in Healthcare Market in Asia-Pacific for Other Application Areas, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
• 21.3. Non-fungible Tokens in Healthcare Market in Asia-Pacific: Distribution by End-user
  • 21.3.1. Non-fungible Tokens in Healthcare Market in Asia-Pacific for Healthcare Professionals, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 21.3.2. Non-fungible Tokens in Healthcare Market in Asia-Pacific for Patients, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 21.3.3. Non-fungible Tokens in Healthcare Market in Asia-Pacific for Pharmaceutical Companies, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 21.3.4. Non-fungible Tokens in Healthcare Market in Asia-Pacific for Academic Institutions / Government Bodies, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 21.3.5. Non-fungible Tokens in Healthcare Market in Asia-Pacific for Insurance Companies, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 21.3.6. Non-fungible Tokens in Healthcare Market in Asia-Pacific for Other End-users, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)

22. MARKET OPPORTUNITY ANALYSIS: MIDDLE EAST AND NORTH AFRICA

• 22.1. Non-fungible Tokens in Healthcare Market in Middle East and North Africa: Distribution by Blockchain Used
  • 22.1.1. Non-fungible Tokens in Healthcare Market in Middle East and North Africa for Ethereum Blockchain, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 22.1.2. Non-fungible Tokens in Healthcare Market in Middle East and North Africa for Hyperledger Blockchain, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 22.1.3. Non-fungible Tokens in Healthcare Market in Middle East and North Africa for Polygon Blockchain, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 22.1.4. Non-fungible Tokens in Healthcare Market in Middle East and North Africa for Other Blockchains, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
• 22.2. Non-fungible Tokens in Healthcare Market in Middle East and North Africa: Distribution by Application Area
  • 22.2.1. Non-fungible Tokens in Healthcare Market in Middle East and North Africa for Health Records Management, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 22.2.2. Non-fungible Tokens in Healthcare Market in Middle East and North Africa for Supply Chain Management, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 22.2.3. Non-fungible Tokens in Healthcare Market in Middle East and North Africa for Genomics Research, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 22.2.4. Non-fungible Tokens in Healthcare Market in Middle East and North Africa for Health and Wellness, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 22.2.5. Non-fungible Tokens in Healthcare Market in Middle East and North Africa for Clinical Trial Consent, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 22.2.6. Non-fungible Tokens in Healthcare Market in Middle East and North Africa for Other Application Areas, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
• 22.3. Non-fungible Tokens in Healthcare Market in Middle East and North Africa: Distribution by End-user
  • 22.3.1. Non-fungible Tokens in Healthcare Market in Middle East and North Africa for Healthcare Professionals, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 22.3.2. Non-fungible Tokens in Healthcare Market in Middle East and North Africa for Patients, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 22.3.3. Non-fungible Tokens in Healthcare Market in Middle East and North Africa for Pharmaceutical Companies, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 22.3.4. Non-fungible Tokens in Healthcare Market in Middle East and North Africa for Academic Institutions / Government Bodies, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 22.3.5. Non-fungible Tokens in Healthcare Market in Middle East and North Africa for Insurance Companies, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 22.3.6. Non-fungible Tokens in Healthcare Market in Middle East and North Africa for Other End-users, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)

23. MARKET OPPORTUNITY ANALYSIS: LATIN AMERICA

• 23.1. Non-fungible Tokens in Healthcare Market in Latin America: Distribution by Blockchain Used
  • 23.1.1. Non-fungible Tokens in Healthcare Market in Latin America for Ethereum Blockchain, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 23.1.2. Non-fungible Tokens in Healthcare Market in Latin America for Hyperledger Blockchain, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 23.1.3. Non-fungible Tokens in Healthcare Market in Latin America for Polygon Blockchain, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 23.1.4. Non-fungible Tokens in Healthcare Market in Latin America for Other Blockchains, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
• 23.2. Non-fungible Tokens in Healthcare Market in Latin America: Distribution by Application Area
  • 23.2.1. Non-fungible Tokens in Healthcare Market in Latin America for Health Records Management, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 23.2.2. Non-fungible Tokens in Healthcare Market in Latin America for Supply Chain Management, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 23.2.3. Non-fungible Tokens in Healthcare Market in Latin America for Genomics Research, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 23.2.4. Non-fungible Tokens in Healthcare Market in Latin America for Health and Wellness, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 23.2.5. Non-fungible Tokens in Healthcare Market in Latin America for Clinical Trial Consent, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 23.2.6. Non-fungible Tokens in Healthcare Market in Latin America for Other Application Areas, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
• 23.3. Non-fungible Tokens in Healthcare Market in Latin America: Distribution by End-user
  • 23.3.1. Non-fungible Tokens in Healthcare Market in Latin America for Healthcare Professionals, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 23.3.2. Non-fungible Tokens in Healthcare Market in Latin America for Patients, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 23.3.3. Non-fungible Tokens in Healthcare Market in Latin America for Pharmaceutical Companies, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 23.3.4. Non-fungible Tokens in Healthcare Market in Latin America for Academic Institutions / Government Bodies, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 23.3.5. Non-fungible Tokens in Healthcare Market in Latin America for Insurance Companies, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
  • 23.3.6. Non-fungible Tokens in Healthcare Market in Latin America for Other End-users, Historical Trends (Since 2021) and Forecasted Estimates (Till 2035)
• *Detailed information on Section VII is available in the Excel Data Packs shared along with the report**

SECTION VIII: STRATEGIC TOOLS

24. PORTER'S FIVE FORCES ANALYSIS

• 24.1. Overview
• 24.2. Significance of Porter's Five Forces Analysis
• 24.3. Methodology
• 24.4. Porter's Five Forces
  • 24.4.1. Threats of New Entrants
  • 24.4.2. Bargaining Power of Buyers
  • 24.4.3. Bargaining Power of NFT Solution Providers
  • 24.4.4. Threats of Substitute Products
  • 24.4.5. Rivalry Among Existing Competitors
• 24.5. Concluding Remarks

SECTION IX: OTHER EXCLUSIVE INSIGHTS

25. CONCLUDING INSIGHTS

26. INSIGHTS FROM PRIMARY RESEARCH

SECTION X: APPENDICES

27. TABULATED DATA

28. LIST OF COMPANIES AND ORGANIZATIONS